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Peripheral Arteriovenous Malformations
with a Dominant Outflow Vein: Results of
Ethanol Embolization
Objective: To assess retrospectively the treatment results of ethanol emboliza-
tion of peripheral arteriovenous malformations (AVMs) with a dominant outflow
vein (DOV).
Materials and Methods: Nineteen patients who had peripheral AVMs with a
DOV were enrolled in this study (mean age, 29.7 years; range, 15 42 years).
Fifty-one ethanol embolizations (mean, 2.7; range, 1 8) were performed by
direct puncture (n = 29), the transarterial approach (n = 13), the transvenous
approach (n = 5), or a combination of methods (n = 4) under general anesthesia.
Coil and/or core-removed guide wire embolization of the DOV or another flow
occlusion technique (i.e., use of an external pneumatic pressure cuff) to achieve
vascular stasis were required in all patients during ethanol embolization. Clinical
follow-up (mean, 22.2 months; range, 1 53 months) was performed for all
patients, and imaging follow-up (mean, 22.1 months; range, 2 53 months) from
the last treatment session was performed for 14 patients. The therapeutic out-
come (cure, improvement, no change, or aggravation) was assessed according
to the clinical response and the degree of devascularization at angiography.
Results: Ethanol embolization was considered as an effective procedure in all
patients. Thirteen (68%) of 19 patients were cured and six displayed improve-
ment. Three of six patients with improvement needed further treatment sessions
for residual AVMs. Four patients (21%) experienced a total of eight complica-
tions. Five complications (three events of a distal embolism and one event each
of a urinary bladder necrosis and a brain infarct related to the accidental cannula-
tion of the common carotid artery during insertion of the Swan-Ganz catheter)
were major and three complications (skin necrosis) were minor.
Conclusion: Peripheral AVMs with a DOV can be effectively treated with a
high cure rate by the use of ethanol embolization alone or in conjunction with the
use of coil and/or core-removed guide wire embolization.
ongenital arteriovenous malformations (AVMs) are a major challenge to
treat in medical practice, and are often associated with serious symptoms
such as heart failure, neuropathy, pain, and bleeding (1 3). Small and
superficial AVMs can be cured with surgical resection; however, most AVMs are
inoperable as they are large and diffuse in nature, and they involve important normal
adjacent structures. With improvement of catheter technology, superselective
techniques, and the use of liquid embolic agents, embolotherapy has emerged as the
primary mode of treatment for the management of peripheral AVMs (3 11).
Nonetheless, the heterogeneity and rarity of peripheral AVMs are obstacles that make
it difficult for interventional radiologists to treat peripheral AVMs effectively.
The target of embolotherapy is the nidus of AVMs, which is an aggregation of arteri-
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Covenous shunts. Recently, to aid in the therapeutic decision
making for performing embolotherapy, Cho et al. (12)
have proposed four prototypes of peripheral AVMs based
on the angiographic morphology of the nidus  these are
arterio-venous fistulae, arteriolo-venous fistulae, arteriolo-
venulous fistulae with a non-dilated fistula, and arteriolo-
venulous fistulae with a dilated fistula. Simultaneously,
these investigators reported that the treatment result of
ethanol embolization for the arteriolo-venous fistulae type
was better than the treatment result of ethanol emboliza-
tion for the other types of fistulae. The AVM type of arteri-
olo-venous fistula has been referred to as an AVM with a
dominant outflow vein (DOV) as the dilated venous
component of the nidus appears as the part of a large
outflow vein on angiography (13). A few other studies
have reported excellent results with the use of embolother-
apy for treating peripheral AVMs with a DOV (9, 13).
Thus, we believe that special attention needs to be applied
to AVMs with a DOV and it is necessary to detail the
procedural aspects of embolotherapy for this subset of
peripheral AVMs.
The purpose of this study was to assess retrospectively
the therapeutic results of ethanol embolization of periph-
eral AVMs with a DOV and to describe the procedural
details of ethanol embolization for this type of AVM.
MATERIALS AND METHODS
Patients
Our institutional review board approved this retrospec-
tive review of patient medical and imaging records and
waived the requirement of informed consent for the study.
Written consent for undergoing a procedure was obtained
from the all patients after a discussion about the
advantages and risks associated with ethanol embolization.
From November 1996 to November 2006, 111 consecu-
tive patients with inoperable peripheral AVMs underwent
staged ethanol embolizations. As in previous studies (9, 12,
14), AVMs with a DOV were defined when multiple arteri-
olar components of the nidus shunted into a dilated venous
component of the nidus that was identified as the part of a
large outflow vein on angiography (Fig. 1). According to
the angiographic classification proposed by Cho et al. (12),
all the angiographic studies of the 111 patients were
retrospectively reviewed by consensus of two radiologists.
Nineteen patients were considered to have AVMs with a
DOV.
The 19 patients consisted of six men and 13 women
(mean age: 29.7 years, age range: 15 42 years). Ethanol
embolization was the primary treatment modality for 15
patients. The remaining four patients had undergone
previous unsuccessful surgery and/or feeding artery
embolization with the use of microcoils. The 19 patients
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Fig. 1. Diagram and angiographic example of peripheral arteriovenous malformations with dominant outflow vein.
A. Peripheral arteriovenous malformations with dominant outflow vein have arteriovenous shunts (S) between multiple arterial
components (A) and dilated venous component (V) of nidus. Dilated venous component of nidus appears as initial part of large outflow
vein on angiography.
B, C. Arterial (B) and venous (C) phases of selective posteroanterior angiogram of arteriovenous malformation with dominant outflow
vein in left forearm show multiple arterial feeders that shunt into wall of large dilated outflow vein (arrows).
A
B
Cdisplayed various presenting symptoms and signs (Table 1).
Pain (68%, 13 of 19 patients) was the most common
symptom. The location of the AVMs was the pelvic wall (n
= 4), the calf (n = 4), the chest wall (n = 3), the hand (n =
2), the uterus (n = 1), the shoulder (n = 1), the foot (n = 1),
the forearm and hand (n = 1), the back muscle (n = 1), and
the retroperitoneum (n = 1). The presence of an AVM was
confirmed by a combination of clinical examination and
the use of imaging studies including magnetic resonance
imaging (MRI), computed tomography (CT) with 3-
dimensional reconstruction, color Doppler flow imaging,
technetium 99m-labeled red blood cell scintigraphy, and/or
diagnostic angiography.
Embolization Procedures and Clinical Follow-Up
All ethanol embolizations were performed under general
anesthesia by three interventional radiologists. A Swan-
Ganz catheter (Baxter Healthcare, Irvine, CA) to monitor
pulmonary artery pressure was inserted at the first session
of ethanol embolization in all patients. During subsequent
sessions of ethanol embolization, the Swan-Ganz catheter
was inserted only when the predicted single injection dose
of absolute ethanol was greater than 3 mL and the total
amount exceeded 0.25 mL per kilogram of body weight
(15). For every embolization session, baseline selective and
superselective angiographic studies were obtained to
determine precisely the flow characteristics of the AVMs.
Transarterial or transvenous catheterization using a
coaxial catheter, and/or percutaneous direct puncture were
needed to reach the nidus being embolized. Initially, the
transarterial approach was preferentially used to embolize
AVMs when possible, as described in previous studies (8,
10). However, in this subset of peripheral AVMs where the
nidus consisted of multiple arteriolar components and a
dilated venous component, we found that superselective
positioning of a catheter to the multiple tortuous arteriolar
components of the nidus required much more time than
approaching the dilated venous component of the nidus via
either a direct puncture or via the transvenous approach.
Furthermore, transarterial embolization was often
abandoned because either severe tortuosity of the arterio-
lar components in the nidus or normal arteriolar branches
arising in very close proximity to the nidus interfered with
accessing to a location that allowed safe embolization. 
Thereafter, either the direct puncture or transvenous
approach was primarily used for embolizing this type of
AVM. When embolization via percutaneous direct
puncture was indicated, the area of percutaneous puncture
was prepared and draped. Subsequently, an 18- or 21-
guage needle (Disposable Cook Modified Needle, Cook,
Bloomington, IN) was advanced under fluoroscopic
guidance.
As all the lesions had a large outflow vein, a few flow
occlusion techniques were applied to achieve vascular
stasis (9). An intravascular occlusion balloon catheter
(Standard Occlusion Balloon Catheter, Boston Scientific,
Natick, MA) was used for lesions located in the trunk and
pelvic area, and external pneumatic pressure cuffs were
used for lesions located in the extremities. However, the
use of coil embolization (Nester coil, Cook, Bloomington,
IN) of the large outflow vein via direct puncture or
transvenous catheterization prior to ethanol injection was
preferred as it allows for a reduction of the amount of
ethanol used and allows for stabilization of the thrombosis
that forms in the large venous component (10, 13). Coil
embolization was not performed for those superficial
lesions that were very close to the skin. For the AVMs with
a larger outflow vein where coil embolization was not
adequate and where the application of an external
pneumatic pressure cuff was not possible, core-removed
guide wire embolization of the outflow vein via direct
puncture or transvenous catheterization was performed
prior to ethanol injection. The core-removed guide wire
used was a 0.035-inch conventional metal guide wire with
a length of 150 cm (M.I.Tech, Seoul, Korea) from which
the inner metallic core was removed.
To determine the volumes of ethanol and injection rates,
test injections of contrast medium were made under fluoro-
scopic monitoring. The amount of ethanol used was based
on the amount of contrast medium required to fill the
AVM nidus without opacifying the normal vessels.
Absolute ethanol (99.9%, J.T. Baker, Selangor, Malaysia)
was used in most cases, and 80% ethanol diluted with
nonionic contrast medium (Xenetix 300, Guerbet, Cedex,
France) was used for the superficial lesions that were
located very close to the skin. The total amount of ethanol
used in a single session was restricted to < 1 mL/kg of body
weight (3, 15). Arteriography was performed 5 to 10
minutes after the ethanol injection to determine whether
the AVMs were completely embolized. Meticulous repeti-
tion of these techniques was required for complete
embolization of at least one compartment of the AVMs.
When the mean pulmonary artery pressure rose above
25 mmHg, nitroglycerine (Nitrolingual, Pohl-Boskamp,
Hohenlockstedt, Germany) was administered as a bolus
injection (50 100  g) and was then infused continuously
at 0.3 3.0  g/kg/min through the Swan-Ganz catheter
until the mean pulmonary artery pressure reached normal
levels. If the pulmonary artery pressure remained elevated
at the end of the session or if a large amount of absolute
ethanol had been injected, the patient was kept in the
intensive care unit for close pulmonary artery pressure
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nmonitoring and continuous administration of nitroglycer-
ine. To control swelling, systemic dexamethasone (0.1
mg/kg) (Dexamethansone, Yuhan, Seoul, Korea) was
administered immediately before the procedure and every
eight hours while the patients were in the hospital. After
the patients were discharged, prednisolone (Solondo,
Yuhan, Seoul, Korea) was administered at 1 mg/kg/day
(maximum daily dose: 15 mg) in three divided doses,
which were tapered over one week.
Periodic (1- to 6-month) follow-up evaluations were
performed based on a physical examination, color Doppler
flow imaging, CT with 3-dimensional reconstruction,
and/or MRI findings during multisession therapy at a
congenital vascular malformation clinic. An additional
embolization was recommended if symptoms and signs
remained or if AVMs remained on follow-up imaging
studies.
Evaluation of Therapeutic Outcome and
Complications
A total of 51 ethanol embolization procedures (mean
2.7, range 1 8) were performed in 19 patients. In 14
patients that required two or more procedures, the time
interval between the procedures ranged from 1 to 16
months (mean 3.7 months, median 3 months). Clinical
follow-up after the last treatment session (mean 22.2
months, range 1 53 months, median 20 months) was
performed for all patients and results from imaging follow-
up after the last treatment session (mean 22.1 months,
range 2 53 months, median 21 months) were available for
14 patients.
Two radiologists analyzed by consensus the therapeutic
response to ethanol embolization by comparing the degree
of AVM devascularization (100%, 76 99%, 50 75%, or
< 50%) between baseline and final angiography. The
clinical response (resolved completely, resolved partially,
no change, or aggravated) and the presence of complica-
tions (major or minor) were evaluated at a congenital
vascular malformation clinic by a consensus of two
vascular surgeons and one interventional radiologist.
Therapeutic outcome was assessed according to the
clinical response and the degree of devascularization at
angiography (10, 12). Cure was defined as complete
resolution of clinical symptoms and signs, with 100%
devascularization of AVMs at angiography. Improvement
was defined as complete or partial resolution of clinical
symptoms and signs, with 50 99% AVM devasculariza-
tion at angiography. No change was defined as partial
resolution or no change of clinical symptoms and signs,
with < 50% devascularization at angiography.
Aggravation was defined as worsening of clinical
symptoms and signs, regardless of the degree of AVM
devascularization at angiography. Cure and improvement
were considered effective therapeutic outcomes of ethanol
embolization of the AVMs.
Major complications included death, permanent adverse
sequelae, the requirement for major therapy, and
prolonged hospitalization (> 48 hours). Minor complica-
tions included any non-permanent adverse sequelae, such
as a spontaneously healed skin injury.
RESULTS
The treatment results of ethanol embolization for the 19
patients with peripheral AVMs with a DOV are presented
in Table 1. During the 51 sessions of ethanol emboliza-
tions, the amount of ethanol used ranged from 2 to 74 mL
in a single session (mean: 34.4 mL, median: 36 mL). Flow
occlusion techniques to achieve vascular stasis were
applied in all patients, but not in all embolization sessions.
Flow occlusion techniques were applied in 37 of 51
embolization sessions, including coil and/or core-removed
guide wire embolization of the outflow vein in 20 sessions,
application of an intravascular occlusion balloon catheter
in two sessions, both of the aforementioned methods in
three sessions, or application of an external pneumatic cuff
in 12 sessions. For 14 embolization sessions, ethanol
embolization was performed without an application of
flow occlusion techniques as the residual AVM was small
or because the application of flow occlusion techniques
could induce reflux of ethanol into the adjacent normal
arteries. Coil and/or core-removed guide wire emboliza-
tion of the outflow vein prior to ethanol injection was
performed in 13 (68%) of 19 patients. Coil embolization
was performed in seven patients (Fig. 2), core-removed
guide wire embolization was performed in two patients,
and both coil embolization and core-removed guide wire
embolization was performed in four patients. The direct
puncture approach was used in 31 of 51 embolization
sessions, the transarterial approach was used in 16 sessions,
and the transvenous approach was used in eight sessions
(multiple approaches in four sessions). Embolization
through direct puncture and/or transvenous approaches
was performed in 17 of 19 AVMs with a DOV. In the other
two patients, ethanol embolization was performed only
through a transarterial approach.
Ethanol embolization achieved an effective therapeutic
outcome in all 19 patients. Thirteen (68%) of the 19
patients were cured, and there was no evidence of
recurrence at imaging and clinical follow-up. In the two
patients that were cured (patients 8 and 13) who
underwent ethanol and core-removed guide wire
Cho et al.
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Fig. 2. 23-year-old woman with pain at
left calf (patient 5).
A, B. Arterial (A) and venous (B)
phases of pretreatment posteroanterior
angiogram show multiple feeding
arteries (arrowheads) with plexiform
appearance and dilated outflow vein
(arrows).
C. Multiple coils (arrows) were placed
into dilated outflow vein through direct
puncture approach, and then 19 mL of
absolute ethanol was injected through
needle.
D. Final posteroanterior angiogram
shows complete obliteration of arteriove-
nous malformation. There was no
evidence of recurrence at 40-month
imaging and clinical follow-up (data not
shown).
AB
CDembolization, devascularized AVMs that contained core-
removed guide wires were surgically removed to reduce
the mass effect of the guide wires, at one month and two
months after completion of embolization, respectively (Fig.
3). Three of the six patients with improvement, in whom
clinical symptoms and signs were completely resolved and
75% of the AVMs were devascularized, finished
treatment as the small residual AVMs were difficult to
access or treat safely. The other three patients with
improvement, in whom clinical symptoms and signs
remained, were waiting for further sessions of ethanol
embolization to treat the residual AVMs.
Eight complications (16%) were encountered in 51
treatment sessions and in four (21%) of 19 patients. Five
complications (three events of a distal embolism and one
event of a brain infarct and one event of urinary bladder
necrosis) were major and three complications (skin
necrosis) were minor. One patient (patient 15) had three
events of a distal embolism and two events of skin necrosis
during eight embolization sessions. Three events of a distal
embolism at the fingers occurred after ethanol emboliza-
tion alone or in conjunction with coil embolization by the
direct puncture approach; two of the embolisms were
resolved by continuous infusion of urokinase overnight,
but the last embolism required amputation of the fifth
finger. Focal necrosis of the urinary bladder occurred after
complete embolization of an AVM in the pelvis, which
healed in two weeks. The brain infarct was related to the
accidental cannulation of the common carotid artery
during insertion of the Swan-Ganz catheter. All of the
Cho et al.
264 Korean J Radiol 9(3), June 2008
AB
Fig. 3. 28-year-old man with painful pulsating mass in left shoulder
(patient 8).
A, B. Arterial (A) and venous (B) phases of pretreatment
posteroanterior angiogram show multiple feeding arteries
(arrowheads) and huge dilated outflow vein (arrows). Note coil
(open arrow) that was previously placed into feeding artery at
another hospital.
C. Arterial phase of left anterior oblique angiogram shows
complete obliteration of arteriovenous malformations after three
sessions of embolization with 40 mL, 55 mL, and 16 mL of
absolute ethanol, respectively, by using direct puncture of dilated
outflow vein. In every session, multiple core-removed guide wires
were placed into outflow vein through direct puncture approach
prior to ethanol injection. Total of 87 core-removed guide wires
(arrows) were placed into outflow vein. Patient complained of
discomfort due to mass effect of guide wires after completion of
embolization and two months later, patient underwent surgical
removal of arteriovenous malformation containing guide wires
without any complications.
Cthree skin necroses healed with wound dressing and a skin
graft was not required. There was no procedure-related
mortality.
DISCUSSION
Arteriovenous malformations with a DOV are found in
about 4% to 20% of peripheral AVMs (9, 12, 14). In the
present study, where the incidence of AVMs with a DOV
was 17% (19 of 111 cases), ethanol embolization alone or
in conjunction with coil and/or core-removed guide wire
embolization achieved effective therapeutic outcomes in
all 19 patients. Thirteen patients (68%) were cured of the
AVMs and six patients achieved improvement during a
clinical follow-up period of 1 53 months and an imaging
follow-up period of 0 53 months. In a previous study,
Jackson et al. (9) reported that four AVMs with a DOV
were effectively treated after ethanol or N-butyl
cyanoacrylate embolization and Yee and Yakes (13)
reported that 27 patients with AVMs containing a DOV
were cured by the use of ethanol alone or in conjunction
with coil embolization. These results are better than the
outcomes for peripheral AVMs overall (8, 10, 11, 16, 17).
Accordingly, Cho et al. (12) reported that the therapeutic
outcome of AVMs with a DOV was better than that of the
other types of AVMs in a study where the investigators
analyzed therapeutic results of ethanol embolization in 66
AVM patients according to an angiographic classification.
Thus, interventional radiologists performing embolother-
apy should realize that peripheral AVMs with a DOV
might be effectively treated with a high cure rate.
The nidus of AVMs with a DOV consists of multiple
arteriolar components and a dilated venous component,
and thus it is clear that approaching the dilated venous
component is easier and simpler than superselective
positioning to the multiple tortuous arteriolar feeders.
Furthermore, based on the present and previous studies (9,
13), an effective therapeutic outcome has mostly been
achieved by embolization through the direct puncture and
transvenous approaches. Jackson et al. (9) and Yee and
Yakes (13) effectively treated AVM patients that had a
DOV by embolotherapy through direct puncture and/or
transvenous approaches. In the present study, direct
puncture and/or transvenous approaches were required for
achieving effective embolization in 17 of 19 AVMs with a
DOV. Although two AVM patients were treated only with
the transarterial approach, transarterial embolization was
considered less effective in our initial experience while the
transarterial approach was preferentially used to embolize
AVMs. Therefore, we believe that the mainstay therapeu-
tic approach for embolizing peripheral AVMs with a DOV
should be the direct puncture or transvenous approach.
As the main target of peripheral AVMs with a DOV is
the venous component of the nidus, liquid or particulate
embolic materials injected through the puncture or
transvenous approach may be swept away from the
venous side before the materials have managed to achieve
occlusion. Even if ethanol, the most powerful sclerosant, is
used, the injected ethanol may become diluted with blood
and may be swept away from the nidus before it causes
nidus occlusion, assuming that the nidus of the AVM type
had a large venous component. Thus, flow occlusion
techniques are required for achieving effective ethanol
embolization of this subset of peripheral AVMs. Jackson et
al. (9) used external pneumatic pressure cuffs and intravas-
cular occlusion balloon catheters to achieve vascular stasis
of four AVMs. Coil embolization of the DOV prior to
ethanol injection was preferred in the present study and
previously by Yee and Yakes (13). This preference was a
because 1) coil embolization of the DOV can reduce the
rate and volume of blood flow within the venous
component of the nidus, thereby reducing the amount of
ethanol required; 2) the coil(s) can hold a large thrombus
that is formed within the large venous component, which
can prevent a pulmonary embolism. Additionally, we
effectively treated six AVMs with a larger DOV, for which
coil embolization was not sufficient and use of an external
pneumatic pressure cuff was not possible, by combining
the use of ethanol and core-removed guide wire emboliza-
tion. Based on our results, core-removed guide wire
embolization of the outflow vein with a larger size can be
one method to make ethanol embolization effective.
However, coil or guide wire embolization has some
drawbacks. These drawbacks are that coils or guide wires
in a very superficial location can erode through the overly-
ing skin and cause ulceration, and in addition, patients can
feel some discomfort due to the mass effect (9). Two
patients complained of discomfort due to the mass effect of
the core-removed guide wires after completion of
embolization, and the devascularized AVMs containing the
guide wires were surgically removed without any compli-
cation one month and two months later, respectively.
Other liquids such as cyanoacrylate and particulate
compounds such as polyvinyl alcohol have been used as
embolic agents for the treatment of peripheral AVMs (16-
19). An ideal cyanoacrylate mixture polymerizes in the
nidus and partial or total occlusion of the nidus can be
achieved. Jackson et al. (9) described two cases of AVMs
with a DOV that were treated by using n-butyl cyanoacry-
late. However, when this agent is used, it is difficult to
control the level of occlusion and there is a risk of a
pulmonary embolism from the escape of the agent. It has
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can recanalize (19, 20). Particulate agents such as
polyvinyl alcohol can induce acute occlusion of AVMs;
however, the lesions usually recanalize during follow-up as
the nidus is not permanently occluded (18, 21). In addition,
these agents may be of limited value for the treatment of
peripheral AVMs with a DOV as particles are usually used
for transarterial embolization.
In the present study, eight (16%) complications were
encountered in 51 treatment sessions and in four (21%) of
19 patients. These results are comparable to the complica-
tion rates (10 30%) of ethanol embolization of peripheral
AVMs overall (3, 6). Reportedly, the most common
complications of ethanol embolization are local tissue
injuries, such as skin necrosis and neuropathy (10). We
encountered three events of skin necrosis at the treated
area and one case of focal urinary bladder necrosis. These
local tissue injuries may be associated with non-target
embolization or ethanol leakage into the adjacent tissues
during embolization. Ethanol injection into the venous
component of the nidus when the venous outflow is
occluded can cause retrograde filling of the arterial feeding
vessels and eventually reflux of ethanol or a thrombus into
the arterial side of the circulation (9). Although Jackson et
al. (9) and Yee and Yakes (13) previously reported no
cases of distal embolism, one patient in our study experi-
enced three events of distal embolism at the fingers. We
started overnight urokinase thrombolysis, as it was very
difficult to differentiate the cause of the distal embolism on
angiography. Two events of distal embolism responded
well to thrombolysis, and we presumed that the cause of
distal embolism might be reflux of a thrombus and not due
to the ethanol. The aforementioned local complications can
be minimized by superselective placement of the catheter
tip or the needle tip, by strictly performing test injections
of contrast medium prior to ethanol injection, and by the
meticulous analysis of angiograms during embolization.
Although the ethanol washed out from the nidus of an
AVM becomes diluted after injection, it can strongly
influence the pulmonary artery pressure (3). If pulmonary
hypertension that is induced by ethanol injection is not
controlled, serious complications may occur, such as a
cardiac arrhythmia and cardiopulmonary collapse (10).
Thus, monitoring of pulmonary and systemic arterial
pressure is essential to minimize the possibility of such
potential complications.
This study has some limitations. First, this is a retrospec-
tive study with a small number of patients. There is a need
for a prospective study involving a significantly large
patient population that would permit assessment that is
more precise. However, the 19 patients in this study were
collected over a 10-year period. The small number of
patients may be due to the rarity of peripheral AVMs in
general and specifically to the rarity of AVMs with a DOV.
Second, the inclusion of the three AVM patients that were
waiting for a further session of staged ethanol embolother-
apy is another limitation of this study, as the outcome of
these patients could change. However, if the patients
awaiting further treatment were excluded, this would lead
to a selection bias, as only AVMs that responded more
easily to treatment would be included in the study.
In conclusion, peripheral AVMs with a DOV can be
effectively treated with a high cure rate by the use of
ethanol embolization alone or in conjunction with the use
of coil and/or core-removed guide wire embolization.
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